HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Samuel S Chong Selected Research
Samuel S Chong Research Topics
Disease
8
Neoplasms (Cancer)
06/2021 - 04/2006
5
Fragile X Syndrome (Martin Bell Syndrome)
05/2022 - 08/2006
5
Hydrops Fetalis (Fetal Edema)
09/2015 - 02/2007
5
Cleft Lip (Harelip)
01/2013 - 04/2007
4
Hepatocellular Carcinoma (Hepatoma)
06/2021 - 01/2019
4
Thalassemia
09/2016 - 03/2013
4
Cleft Palate (Palate, Cleft)
01/2014 - 01/2012
4
Disease Susceptibility (Diathesis)
06/2007 - 04/2004
3
Intellectual Disability (Idiocy)
01/2018 - 11/2006
3
beta-Thalassemia (Cooley's Anemia)
09/2016 - 02/2003
2
Rheumatoid Arthritis
10/2022 - 01/2022
2
Carcinogenesis
06/2021 - 06/2005
2
Fibrosis (Cirrhosis)
01/2019 - 01/2019
2
Disease Progression
01/2019 - 04/2005
2
Huntington Disease (Huntington's Disease)
01/2019 - 01/2016
2
alpha-Thalassemia
09/2015 - 03/2006
2
Pre-Eclampsia (Preeclampsia)
12/2009 - 05/2008
2
Van der Woude syndrome
04/2007 - 06/2005
1
Myalgia
01/2021
1
Chronic Hepatitis B
01/2019
1
Infections
01/2019
1
Autism Spectrum Disorder
01/2018
1
Myotonic Dystrophy (Dystrophia Myotonica)
06/2017
1
Colorectal Neoplasms (Colorectal Cancer)
01/2014
1
Genetic Translocation (Chromosomal Translocation)
10/2012
1
Klinefelter Syndrome (Klinefelter's Syndrome)
12/2006
1
Azoospermia
12/2006
1
Lung Diseases (Lung Disease)
08/2006
1
Asthma (Bronchial Asthma)
08/2006
1
Bronchiectasis
08/2006
1
Aneuploidy (Aneuploid)
04/2006
1
Chromosomal Instability (Chromosome Stability)
04/2006
1
Virus Diseases (Viral Diseases)
06/2005
1
Popliteal Pterygium Syndrome
06/2005
1
Pterygium
06/2005
1
Lipoid Nephrosis (Glomerulonephritis, Minimal Change)
04/2005
1
Parkinson Disease (Parkinson's Disease)
12/2004
1
Inborn Genetic Diseases (Disease, Hereditary)
05/2002
Drug/Important Bio-Agent (IBA)
10
Prostaglandins D
IBA
06/2017 - 05/2002
4
Biomarkers (Surrogate Marker)
IBA
01/2021 - 01/2014
4
hemoglobin Bart's
IBA
09/2015 - 10/2009
4
Pharmaceutical Preparations
IBA
01/2014 - 04/2004
3
Messenger RNA (mRNA)
IBA
06/2021 - 10/2019
3
MicroRNAs (MicroRNA)
IBA
06/2021 - 01/2019
3
DNA (Deoxyribonucleic Acid)
IBA
01/2018 - 02/2003
3
Globins
IBA
09/2016 - 11/2010
3
5' Untranslated Regions (5' UTR)
IBA
02/2012 - 08/2006
2
Methotrexate (Mexate)
FDA Link
Generic
10/2022 - 01/2022
2
Long Noncoding RNA
IBA
01/2021 - 01/2020
2
Proteins (Proteins, Gene)
FDA Link
10/2019 - 04/2006
2
Ubiquitin
IBA
12/2014 - 04/2006
2
Nucleotides
IBA
01/2013 - 03/2006
2
Interferon Regulatory Factors
IBA
04/2007 - 06/2005
1
messenger ribonucleoprotein
IBA
05/2022
1
Circular RNA
IBA
06/2021
1
Atorvastatin (Lipitor)
FDA Link
01/2021
1
Capsules (Microcapsules)
IBA
01/2020
1
Metallothionein
IBA
01/2020
1
RNA (Ribonucleic Acid)
IBA
01/2019
1
Cyclic AMP-Dependent Protein Kinases (cAMP-Dependent Protein Kinase)
IBA
01/2019
1
Intergenic DNA (Junk DNA)
IBA
01/2019
1
Protein Kinases (Protein Kinase)
IBA
06/2017
1
Complement System Proteins (Complement)
IBA
01/2016
1
alpha-Globins
IBA
06/2015
1
Capecitabine (Xeloda)
FDA Link
01/2014
1
Prodrugs
IBA
01/2014
1
Smoke
IBA
01/2014
1
Fluorouracil (Carac)
FDA Link
Generic
01/2014
1
Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)
IBA
01/2013
1
Biological Products
IBA
01/2013
1
HLA Antigens (Human Leukocyte Antigens)
IBA
10/2012
1
Receptor Tyrosine Kinase-like Orphan Receptors
IBA
02/2012
1
Bone Morphogenetic Protein 4
IBA
01/2012
1
Polymers
IBA
01/2010
1
HLA-G Antigens (HLA G)
IBA
12/2009
1
Ligands
IBA
12/2009
1
Transforming Growth Factor alpha (TGF-alpha)
IBA
09/2009
1
HLA-G*01:06 antigen
IBA
05/2008
1
Gonadotropins
IBA
12/2006
1
Cystic Fibrosis Transmembrane Conductance Regulator (Protein, CFTR)
IBA
08/2006
1
Terminator Codon (Termination Codon)
IBA
03/2006
1
human AZU1 protein
IBA
06/2005
1
Cysteine (L-Cysteine)
FDA Link
06/2005
1
Complementary DNA (cDNA)
IBA
06/2005
1
Interferon-alpha (Interferon Alfa)
IBA
06/2005
1
Interleukin-13
IBA
04/2005
1
3' Untranslated Regions (3' UTR)
IBA
04/2005
1
Xenobiotics
IBA
12/2004
1
beta-Globins (beta Globin)
IBA
02/2003
Therapy/Procedure
1
Therapeutics
01/2019